Enlivex Ltd.

XNAS:ENLV

1.04

-0.03 (-2.80%)

7:51:57 PM EDT: $1.06 +0.02 (+1.92%)

Enlivex Therapeutics Ltd Stock, XNAS:ENLV

14 Einstein Street, 14 Einstein Street, Ness Ziona, Tel Aviv 7403618

Israel

Phone: +972.8.662.3301

Number of Employees: 49

http://www.enlivex.com

Description

Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.